Company Filing History:
2 out of 259 
1 out of 3 Years Active: 2014-2015
Title: David John Matthews: Innovator in Antibody Research
Introduction
David John Matthews is a notable inventor based in London, GB. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies for medical applications. With a total of two patents to his name, Matthews has focused on addressing critical health issues through innovative solutions.
Latest Patents
Matthews' latest patents include groundbreaking work on hepatitis C virus antibodies. This invention relates to humanized antibodies and fragments that bind to the hepatitis C virus E2 protein, along with methods for their use. Another significant patent involves antibodies against IL-25. This invention pertains to IL-25 antibody VH domains and target binding members that comprise such domains, which bind IL-25. The invention also covers compositions that include these target binding members and methods for their production, aimed at treating or preventing diseases such as asthma and inflammatory bowel disease.
Career Highlights
Throughout his career, Matthews has worked with esteemed organizations, including the Medical Research Council and Medical Research Council Technology. His work in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
Matthews has collaborated with several professionals in his field, including Jillian Barlow and Andrew Neil James McKenzie. These collaborations have further enriched his research and innovation efforts.
Conclusion
David John Matthews stands out as an influential inventor in the realm of antibody research. His contributions have the potential to impact the treatment of various diseases significantly.